Use of TNF-alpha binding proteins and IL-7 binding proteins in medical treatment

The present disclosure relates to the use of TNF-[alpha] binding proteins and interleukin 7 (IL-7) binding proteins in the treatment of autoimmune and/or inflammatory conditions. The disclosure also relates to methods of treating diseases with TNF-[alpha] binding proteins and IL-7 binding proteins....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TOCKER, JOEL, MORLEY, PETER JOSEPH, RYCROFT, DANIEL, ASHMAN, CLAIRE, LICH, JOHN, DIXON, DAVID, SOKOLOVE, JEREMY, LEWIS, ALAN PETER, NEISEN, JESSICA LYNN, HOPLEY, STEPHANIE, TICKLE, JOSEPH R, NAGPAL, SUNIL, COULSTOCK, EDWARD THOMAS, BOUMA, GERBEN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to the use of TNF-[alpha] binding proteins and interleukin 7 (IL-7) binding proteins in the treatment of autoimmune and/or inflammatory conditions. The disclosure also relates to methods of treating diseases with TNF-[alpha] binding proteins and IL-7 binding proteins. The disclosure further relates to bispecific antibodies binding to TNF-[alpha] and IL-7, uses of such bispecific antibodies, pharmaceutical compositions comprising such bispecific antibodies and methods of their manufacture.